SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 278 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $44,890,000 | -17.6% | 263,301 | -22.5% | 0.27% | -35.0% |
| Q2 2020 | $54,474,000 | -99.8% | 339,743 | 0.0% | 0.42% | +35.5% |
| Q1 2020 | $31,596,099,000 | -27.9% | 339,743 | 0.0% | 0.31% | +5.8% |
| Q4 2019 | $43,840,437,000 | +171225.3% | 339,743 | 0.0% | 0.29% | +64.6% |
| Q3 2019 | $25,589,000 | -68.3% | 339,743 | -36.0% | 0.18% | -67.9% |
| Q2 2019 | $80,635,000 | +0.0% | 530,675 | -13.5% | 0.55% | -2.8% |
| Q1 2019 | $80,597,000 | -10.9% | 613,210 | -26.0% | 0.57% | -25.6% |
| Q4 2018 | $90,472,000 | -31.5% | 829,037 | +1.4% | 0.77% | -19.1% |
| Q3 2018 | $132,101,000 | +91.3% | 817,916 | +56.6% | 0.95% | +74.1% |
| Q2 2018 | $69,042,000 | +38.2% | 522,334 | -24.9% | 0.54% | +40.2% |
| Q1 2018 | $49,951,000 | +29.0% | 695,904 | 0.0% | 0.39% | -5.8% |
| Q4 2017 | $38,720,000 | – | 695,904 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |